GSVA results (Fig. 2D) highlighted distinct activity levels in numerous immune, drug metabolism, and cancer-related pathways, including B/T/NK cell receptor signaling, toll-like receptor signaling, antigen processing and presentation, drug metabolism via cytochrome P450, and melanogenesis. Here, KLRD1 is linked to cancer.